Food for thought based on the evidence of chemotherapy for elderly patients with advanced non-small cell lung cancer
  
View Full Text  View/Add Comment  Download reader
DOI:10.3724/SP.J.1264.2012.00148
Key words:elderly  non-small cell lung cancer  chemotherapy
Author NameAffiliationE-mail
WANG Binchao, WU Yilong Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China wbc_gz@hotmail.com 
Hits: 1560
Download times: 2307
Abstract:
      Paradigm of chemotherapy for elderly patients with advanced non-small cell lung cancer (NSCLC) remains immature. High-level evidence of chemotherapy for geriatric advanced NSCLC, which contributes to the update of guideline for clinical practice worldwide, was reviewed and analyzed. In light of those evidence, it is generally accepted that single agent chemotherapy is recommended and platin-base doublet is an alternative for elderly patients with advanced NSCLC. In the meantime, it was also suggested that elderly patients with advanced NSCLC have heterogeneity and the management of those patients is de facto an issue of how to arrive at further sub-classification by virtue of their clinical features such as performance status, comorbidity, vital organ function, and so on.
Close